Automation index

How much of a Growth manager’s job can AI already do?

An A/B test and a funnel report come earlier. Picking this week’s bet and fighting for budget do not.

This percentage does not predict how many people will lose their jobs.

Task comparison

IS WORK OVER?

31%

AI can already do 31% of this job.

#35 / 643

Growth manager

Task weights are our estimates based on O*NET frequency data, not time shares published by O*NET.

The time saving for each task is estimated separately.

Task	Share	AI	Points
Analytics, funnels and growth dashboards. Estimate No public source provides a precise figure. This is our estimate.	22%	52%	+11.4
Copy, creatives and test variants. Estimate No public source provides a precise figure. This is our estimate.	18%	48%	+8.6
Design experiments and read causality. Estimate No public source provides a precise figure. This is our estimate.	16%	22%	+3.5
Align product, marketing and sales. Estimate No public source provides a precise figure. This is our estimate.	16%	15%	+2.4
Ads budget and internal negotiation. Estimate No public source provides a precise figure. This is our estimate.	14%	18%	+2.5
Decide what dies and what scales. Estimate No public source provides a precise figure. This is our estimate.	14%	16%	+2.2
Total	100%		31%

Modelled workweek: 100% · Public evidence: 0% · Estimate: 100% · Confidence: Low

IS WORK OVER?

27%

#168 / 643

Immunologist

Task weights are our estimates based on O*NET frequency data, not time shares published by O*NET.

The time saving for each task is estimated separately.

Task	Share	AI	Points
Panel, autoantibodies and the report. Estimate No public source provides a precise figure. This is our estimate.	18%	48%	+8.6
Clinic, the flare and the one that does not fit. Estimate No public source provides a precise figure. This is our estimate.	16%	40%	+6.4
Immunosuppressant, the dose and not dropping extra. Estimate No public source provides a precise figure. This is our estimate.	16%	22%	+3.5
Infection, the risk and vaccinating on time. Estimate No public source provides a precise figure. This is our estimate.	16%	28%	+4.5
The internist, the board and not delaying the biologic. Estimate No public source provides a precise figure. This is our estimate.	18%	14%	+2.5
Call it autoimmune, and sign the treatment. Estimate No public source provides a precise figure. This is our estimate.	16%	12%	+1.9
Total	100%		27%

Modelled workweek: 100% · Public evidence: 0% · Estimate: 100% · Confidence: Low